RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Firas Kobaissy to Alzheimer Disease

This is a "connection" page, showing publications Firas Kobaissy has written about Alzheimer Disease.
Connection Strength

0.380
  1. Wang B, Pan X, Teng IT, Li X, Kobeissy F, Wu ZY, Zhu J, Cai G, Yan H, Yan X, Liang M, Yu F, Lu J, Yang Z, Biondi E, Haskins W, Cao YC, Benner SA, Tan W, Wang KK. Functional Selection of Tau Oligomerization-Inhibiting Aptamers. Angew Chem Int Ed Engl. 2024 Apr 24; 63(18):e202402007.
    View in: PubMed
    Score: 0.141
  2. Watson CN, Begum G, Ashman E, Thorn D, Yakoub KM, Hariri MA, Nehme A, Mondello S, Kobeissy F, Belli A, Di Pietro V. Co-Expression Analysis of microRNAs and Proteins in Brain of Alzheimer's Disease Patients. Cells. 2022 Jan 04; 11(1).
    View in: PubMed
    Score: 0.121
  3. Mallah K, Zibara K, Kerbaj C, Eid A, Khoshman N, Ousseily Z, Kobeissy A, Cardon T, Cizkova D, Kobeissy F, Fournier I, Salzet M. Neurotrauma investigation through spatial omics guided by mass spectrometry imaging: Target identification and clinical applications. Mass Spectrom Rev. 2023 Jan; 42(1):189-205.
    View in: PubMed
    Score: 0.118
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support